Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Treatment with PF-05231023 improves lipid parameters in patients with type 2 diabetes

July 16, 2014

Serum peptide signature detects early-stage lung cancer

July 16, 2014

Gene signature correlated with prognosis in colorectal cancer

July 16, 2014

G-Pen shows promising results in a phase II trial

July 15, 2014

NPT-088, a dimeric fusion protein for the treatment of AD

July 15, 2014

Results of a first-in-human study of Axon's novel tau vaccine

July 15, 2014

XMetA demonstrates efficacy in animal models of diabetes

July 15, 2014

New clinical data on remogliflozin etabonate presented

July 14, 2014

Hanmi presents promising results for HM-71224

July 14, 2014

BioChaperone Lispro demonstrates a faster onset of action than naive insulin lispro

July 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.